MyFinsight
Home
About
Contact
adil: the income statement
Download
Download image
Net loss
-$1,793,651
(18.17%↑ Y/Y)
Total other income
(expense)
-$29,573
Loss from operations
-$1,764,078
(20.23%↑ Y/Y)
Interest income
$47,860
Other income
(expenses)
-$513
Loss on equity method
investment
-$76,920
Total operating
expenses
$1,764,078
General and
administrative expenses
$1,243,009
Research and development
expenses
$521,069
Back
Back
Income Statement
source: myfinsight.com
ADIAL PHARMACEUTICALS, INC. (ADIL)
ADIAL PHARMACEUTICALS, INC. (ADIL)